Sirona Biochem Corp.
SBM.V
TSX
| 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | 07/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -15.85% | -7.13% | -20.37% | 32.45% | 38.56% |
| Total Depreciation and Amortization | 5.71% | 395.83% | 4.29% | 2.82% | -1.41% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 26.49% | 62.75% | 79.47% | -87.15% | -76.27% |
| Change in Net Operating Assets | 723.57% | -151.83% | -148.27% | 279.35% | -60.55% |
| Cash from Operations | -6.00% | -23.47% | -25.99% | 23.36% | 11.84% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 0.20% | -42.76% | -- | -- | -- |
| Total Debt Repaid | 64.54% | 79.54% | 115.10% | 89.51% | 74.30% |
| Issuance of Common Stock | 451.62% | 22.66% | -98.63% | -97.81% | -98.46% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 25.83% | -28.83% | -1.56% | -19.97% | -60.85% |
| Foreign Exchange rate Adjustments | 175.25% | 173.17% | 170.34% | 171.67% | -237.53% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 66.90% | -93.93% | -175.59% | 140.69% | -183.22% |
